Reversibly Shielded DNA Polyplexes Based on Bioreducible PDMAEMA-SS-PEG-SS-PDMAEMA Triblock Copolymers Mediate Markedly Enhanced Nonviral Gene Transfection
- 10 February 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 13 (3), 769-778
- https://doi.org/10.1021/bm201693j
Abstract
Reversibly shielded DNA polyplexes based on bioreducible poly(dimethylaminoethyl methacrylate)-SS-poly(ethylene glycol)-SS-poly(dimethylaminoethyl methacrylate) (PDMAEMA-SS-PEG-SS-PDMAEMA) triblock copolymers were designed, prepared and investigated for in vitro gene transfection. Two PDMAEMA-SS-PEG-SS-PDMAEMA copolymers with controlled compositions, 6.6–6–6.6 and 13–6–13 kDa, were obtained by reversible addition–fragmentation chain transfer (RAFT) polymerization of dimethylaminoethyl methacrylate (DMAEMA) using CPADN-SS-PEG-SS-CPADN (CPADN: 4-cyanopentanoic acid dithionaphthalenoate; PEG: 6 kDa) as a macro-RAFT agent. Like their nonreducible PDMAEMA-PEG-PDMAEMA analogues, PDMAEMA-SS-PEG-SS-PDMAEMA triblock copolymers could effectively condense DNA into small particles with average diameters less than 120 nm and close to neutral zeta potentials (0 ∼ +6 mV) at and above an N/P ratio of 3/1. The resulting polyplexes showed excellent colloidal stability against 150 mM NaCl, which contrasts with polyplexes of 20 kDa PDMAEMA homopolymer. In the presence of 10 mM dithiothreitol (DTT), however, polyplexes of PDMAEMA-SS-PEG-SS-PDMAEMA were rapidly deshielded and unpacked, as revealed by significant increase of positive surface charges as well as increase of particle sizes to over 1000 nm. Release of DNA in response to 10 mM DTT was further confirmed by gel retardation assays. These polyplexes, either stably or reversibly shielded, revealed a low cytotoxicity (over 80% cell viability) at and below an N/P ratio of 12/1. Notably, in vitro transfection studies showed that reversibly shielded polyplexes afforded up to 28 times higher transfection efficacy as compared to stably shielded control under otherwise the same conditions. Confocal laser scanning microscope (CLSM) studies revealed that reversibly shielded polyplexes efficiently delivered and released pDNA into the perinuclei region as well as nuclei of COS-7 cells. Hence, reduction-sensitive reversibly shielded DNA polyplexes based on PDMAEMA-SS-PEG-SS-PDMAEMA are highly promising for nonviral gene transfection.Keywords
This publication has 58 references indexed in Scilit:
- Nonviral Vectors for Gene DeliveryChemical Reviews, 2008
- Gene therapy progress and prospects: synthetic polymer-based systemsGene Therapy, 2008
- Progress in developing cationic vectors for non-viral systemic gene therapy against cancerBiomaterials, 2008
- Molecular design of functional polymers for gene therapyProgress in Polymer Science, 2007
- Death Prompts a Review of Gene Therapy VectorScience, 2007
- Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity☆Advanced Drug Delivery Reviews, 2006
- Artificial viruses: a nanotechnological approach to gene deliveryNature Reviews Drug Discovery, 2006
- Steric stabilization of poly(2‐(dimethylamino)ethyl methacrylate)‐based polyplexes mediates prolonged circulation and tumor targeting in miceThe Journal of Gene Medicine, 2004
- A comparative study of different cationic transfection agents for in vivo gene delivery after intravenous administrationJournal of Drug Delivery Science and Technology, 2004
- A triploblast origin for Myxozoa?Nature, 1998